FASA Sec. 1555 cooperative purchasing program escapes repeal; ADAP funds not added to appropriations.
FASA SEC. 1555 REPEAL PROVISION STRIPPED FROM SUPPLEMENTAL APPROPRIATIONS legislation (S 672/HR 1469) during the House/Senate conference on the bill May 20. Legislators instead decided to extend an existing moratorium on implementation of Sec. 1555 of the Federal Acquisition Streamlining Act, which would establish a voluntary cooperative purchasing program granting state and local agencies access to federal prices on goods including pharmaceuticals. The moratorium is scheduled to last until the end of the current Congressional session.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth